日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Release of apoptosis inhibitor of macrophage (AIM) from pentameric IgM in serum predicts prognosis after hemodialysis initiation

血清中五聚体IgM释放的巨噬细胞凋亡抑制因子（AIM）可预测血液透析开始后的预后

期刊:
影响因子:
doi:10.1038/s43856-025-00735-8
Yasuda, Keisuke; Nishijima, Akemi; Inoue, Tomoko; Takagi, Toshio; Tanabe, Kazunari; Minakuchi, Jun; Arai, Satoko; Miyazaki, Toru
表观遗传
免疫/内分泌
巨噬细胞
IgM
凋亡
细胞生物学
巨噬细胞
发表日期：2025
文献求助 收藏

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort

脂质体艾立布林（E7389-LF）联合纳武利尤单抗治疗胃癌队列的II期研究结果

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1768
Kawazoe, Akihito; Yamamoto, Noboru; Sugimoto, Naotoshi; Kawakami, Hisato; Oshima, Takashi; Yamaguchi, Kensei; Hino, Kaori; Hirao, Motohiro; Kurokawa, Yukinori; Kawakami, Takeshi; Tsuda, Masahiro; Hara, Hiroki; Kaname, Shota; Matsuoka, Daiko; Otake, Yohei; Yasuda, Keisuke; Takase, Takao; Takashima, Shuya; Semba, Taro; Muro, Kei
胃癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Nuclear receptor 4A1 (NR4A1) upregulated by n-butylidenephthalide via the mitogen-activated protein kinase (MAPK) pathway ameliorates drug-induced gingival enlargement.

核受体 4A1 (NR4A1) 通过丝裂原活化蛋白激酶 (MAPK) 通路被 n-丁烯基酞上调，从而改善药物引起的牙龈增生

期刊:Biofactors
影响因子:5
doi:10.1002/biof.2077
Ueda Tomoya, Matsuda Shinji, Ninomiya Yurika, Nakashima Fuminori, Yasuda Keisuke, Furutama Daisuke, Memida Takumi, Yoshimoto Tetsuya, Kajiya Mikihito, Ohta Kouji, Ouhara Kazuhisa, Mizuno Noriyoshi
信号转导
MAPK/ERK
药物研究
发表日期：2024
文献求助 收藏

Phase 1b/2 study of the liposomal formulation of eribulin (E7389-LF) in combination with nivolumab: Results from the phase 2 esophageal cancer cohort

脂质体艾立布林（E7389-LF）联合纳武利尤单抗的1b/2期研究：来自2期食管癌队列的结果

期刊:
影响因子:
doi:10.1038/s44276-024-00066-6
Oshima, Takashi; Yamamoto, Sachiko; Kawakami, Hisato; Makino, Tomoki; Kawazoe, Akihito; Masuishi, Toshiki; Tsushima, Takahiro; Hirao, Motohiro; Tsuda, Masahiro; Hino, Kaori; Yamamoto, Noboru; Hara, Hiroki; Kaname, Shota; Matsuoka, Daiko; Otake, Yohei; Yasuda, Keisuke; Takase, Takao; Takashima, Shuya; Semba, Taro; Ooki, Akira
食管癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Phase Ib/II Study of a Liposomal Formulation of Eribulin (E7389-LF) plus Nivolumab in Patients with Advanced Solid Tumors: Results from Phase Ib

艾立布林脂质体制剂（E7389-LF）联合纳武利尤单抗治疗晚期实体瘤患者的Ib/II期研究：Ib期研究结果

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-22-0401
Ida, Hanae; Shimizu, Toshio; Nishino, Makoto; Nakamura, Yoshiaki; Yazaki, Shu; Katsuya, Yuki; Sato, Jun; Koyama, Takafumi; Iwasa, Satoru; Sudo, Kazuki; Kondo, Shunsuke; Yonemori, Kan; Shitara, Kohei; Shiono, Satoshi; Matsuoka, Daiko; Yasuda, Keisuke; Otake, Yohei; Suzuki, Takuya; Takase, Takao; Takashima, Shuya; Yamaguchi, Kohei; Semba, Taro; Yamamoto, Noboru
发表日期：2023
文献求助 收藏

Bone turnover markers to assess jawbone quality prior to dental implant treatment: a case-control study

骨转换标志物在牙种植治疗前评估颌骨质量的应用：一项病例对照研究

期刊:International Journal of Implant Dentistry
影响因子:4
doi:10.1186/s40729-020-00264-0
Yasuda, Keisuke; Okada, Shinsuke; Okazaki, Yohei; Hiasa, Kyou; Tsuga, Kazuhiro; Abe, Yasuhiko
发表日期：2020
文献求助 收藏

Bioactive surface modification of hydroxyapatite

羟基磷灰石的生物活性表面改性

期刊:Biomed Research International
影响因子:2.6
doi:10.1155/2013/626452
Yasuhiko Abe, Yohei Okazaki, Kyou Hiasa, Keisuke Yasuda, Keisuke Nogami, Wataru Mizumachi, Isao Hirata
信号转导
发表日期：2013
文献求助 收藏